v3.22.2.2

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenues	$ 2,634	$ 5,854	$ 7,425	$ 9,589
Cost and operating expenses:
Research and development	31,186	50,152	59,925	89,963
Sales and marketing	3,158	7,904	6,796	14,776
General and administrative	24,294	23,661	47,999	42,992
Goodwill impairment charge	40,645	0	40,645	0
Restructuring charges (benefit)	(185)	0	(315)	0
Total cost and operating expenses	108,830	103,546	177,237	190,690
Operating loss	(106,196)	(97,692)	(169,812)	(181,101)
Other income (expense):
Interest income	2	12	53	55
Interest expense	(9,378)	(2,767)	(17,423)	(5,494)
Gain (loss) on change in fair value of warrant liabilities	0	(430)	0	1,849
Other expense, net	(885)	(5)	(1,417)	(768)
Total other expense	(10,261)	(3,190)	(18,787)	(4,358)
Loss before income taxes	(116,457)	(100,882)	(188,599)	(185,459)
Benefit from (provision for) income taxes	(11)	16	15	8
Net loss and comprehensive loss	(116,468)	(100,866)	(188,584)	(185,451)
Net loss and comprehensive loss	$ (116,468)	$ (100,866)	$ (188,584)	$ (185,451)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (1.13)	$ (1.30)	$ (1.83)	$ (4.07)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (1.13)	$ (1.30)	$ (1.83)	$ (4.10)
Weighted average shares used in computing net loss per share to common stockholders, basic (in shares)	103,482,907	77,671,643	103,297,070	45,512,654
Weighted average shares used in computing net loss per share to common stockholders, diluted (in shares)	103,482,907	77,671,643	103,297,070	45,727,153
Revenues from research and development service agreements
Revenues	$ 1,191	$ 4,846	$ 4,412	$ 7,460
Collaboration and other revenue
Revenues	746	1,008	2,079	2,129
Automation revenue
Revenues	480	0	480	0
Cost and operating expenses:
Cost of revenue	637	0	637	0
Grant revenue
Revenues	217	0	454	0
Service revenue
Cost and operating expenses:
Cost of revenue	$ 9,095	$ 21,829	$ 21,550	$ 42,959

Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(22))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(24))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(26))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580

Zymergen Inc. 10-Q